Case Report: Complete response with combination oncolytic virus immunotherapy in a patient with stage IV renal cell carcinoma—a promising innovative approach

Case Report: Complete response with combination oncolytic virus immunotherapy in a patient with stage IV renal cell carcinoma—a promising innovative approach

Metastatic renal cell carcinoma stage IV (RCC-IV) remains a therapeutic challenge, with an overall 5-year survival rate of 12%. Conventional chemotherapy and radiotherapy have shown relatively low efficacy in reducing morbidity and mortality, whereas innovative immunotherapies have demonstrated prom...

Full description

Saved in:
Bibliographic Details
Main Authors: Benjamin Gesundheit, Chaim Brauns, Thomas J. Vogl, Alexander Muckenhuber, Christine Weisslein, Harald Schmoll, Ronald Ellis, Yehudit Posen, Jayadeepa Srinivas Raju
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Oncology
Subjects:
renal cell carcinoma
oncolytic virotherapy
intratumoral
immunotherapy
abscopal effect
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1631155/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2025.1631155/full

Similar Items